期刊文献+

破骨细胞分化因子及其相关因子在中耳胆脂瘤组织的表达 被引量:3

Expression of RANK-RANKl-OPG system in middle ear cholesteatoma
下载PDF
导出
摘要 目的探讨破骨细胞分化因子(nuclear factor-kappa B ligand,RANKL)和其配体核因子-κB受体活化因子(receptor activator of nuclear factor-kappa B,RANK)及假性受体骨保护素(osteoprotegerin,OPG)即RANK-RANKL-OPG系统在中耳胆脂瘤的作用,儿童中耳胆脂瘤较成人骨质破坏严重的原因。方法应用免疫组织化学SP法观察RANKL和OPG在21例成人中耳胆脂瘤组织、17例儿童中耳胆脂瘤组织和18例正常外耳道深部皮肤中的表达,对染色结果进行量化处理和统计学分析。结果RANKL和RANKL/OPG比值在胆脂瘤的表达量明显高于外耳道皮肤,儿童胆脂瘤高于成人,差异有统计学意义(P<0.05)。结论①RANKL和RANKL/OPG比值的增高与胆脂瘤的骨质破坏有关,在中耳胆脂瘤骨质破坏的机制中起重要作用;②儿童中耳胆脂瘤RANKL/OPG比值较高,这可能是导致儿童中耳胆脂瘤比成人发展快,骨质破坏严重的一个重要原因。 OBJECTIVE To investigate the effect of nuclear factor-kappa B ligand-receptor activator of nuclear factor-kappa B-osteoprotegerin(RANKRANKL-OPG)system on bone resorption in middle ear cholesteatoma,and the reasons why middle ear cholesteatoma in children were more aggressive. METHODS The expression of RANKL and OPG in 21 adults cholesteatoma,17 children cholesteatoma and 18 normal external meatal skin was studied with immunohistochemistry. Semiquantitative analysis was used for comparison and statistical analysis. RESULTS RANKL-positive cells and the ratio of RANKL/OPG in cholesteatoma were significantly higher than that in external meatal skin (P〈0.05) . RANKL-positive cells and the ratio of RANKL/OPG in cholesteatoma of children were higher than that in adults (P〈0.05) . CONCLUSION The overexpression of RANKL and the increased ratio of RANKL/OPG in cholesteatoma were associated with the bone resorption. The ratio of RANKL/OPG in cholesteatoma of children was higher. Therefore, it may be an important reason why cholesteatoma in child could cause more extensive bone resorption.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2009年第10期579-581,共3页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 胆脂瘤 中耳 破骨细胞 儿童 成年人 Cholesteatoma Middle Ear Osteoclasts Child Adult
  • 相关文献

参考文献8

  • 1Blair JM, Zhou H, Seibel M J, et al. Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat Clin Pract Oncol, 2006, 3: 41-49.
  • 2Dai JC, He P, Chen X, et al. TNFalpha and PTH utilize distinct mechanism to induce IL-6 and RANKL expression with markedly differentkinetics. Bone, 2006, 38: 509-520.
  • 3Hamzei M, Ventriglia G, Hagnia M, et al. Osteoclast stimulating and differentiating factors in human cholesteatoma. Laryngoscope, 2003, 113: 436-442.
  • 4Jeong JH, Park CW, Tae K, et al. Expression of RANKL and OPG in middle ear cholesteatoma tissue. Laryngoscope, 2006, 116: 1180-1184.
  • 5潘松林,龚树生,贺红斌.细胞外凋亡途径与中耳胆脂瘤细胞凋亡[J].中国耳鼻咽喉头颈外科,2007,14(12):699-701. 被引量:8
  • 6Bujia J, Holly A, Antoli-Candela F, et al. Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1. Laryngoscope, 1996, 106 865-868.
  • 7马艳利,叶胜难.炎症激活的破骨细胞在胆脂瘤骨破坏中的作用[J].国际耳鼻咽喉头颈外科杂志,2006,30(3):164-166. 被引量:2
  • 8惠莲,姜学钧,杨柠.小儿胆脂瘤型中耳炎的鼓室成形术[J].中华耳鼻咽喉头颈外科杂志,2005,40(9):653-656. 被引量:10

二级参考文献37

  • 1[1]Schulz P,Bujia J,Holly A,et al.Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.Am J Otolaryngol,1993,14:82-87.
  • 2[2]Wajant H.Death receptors.Essays Biochem,2003,39:53-71.
  • 3[3]Harvey NL,Kumar S.The role of caspases in apoptosis.Adv Biochem Eng Biotechnol,1998,62:107-128.
  • 4[4]Bratton SB,MacFarlane M,Cain K,et al.Protein complexes activate distinct caspase cascades in death receptor and stressinduced apoptosis.Exp Cell Res,2000,256:27-33.
  • 5[5]Wolf B,Schuler M,Echeverri F,et al.Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation.J Biol Chem,1999,274:30651-30656.
  • 6[6]Park H J,Park K.Expression of Fas/APO-1 and apoptosis of keratinocytes in human cholesteatoma.Laryngoscope,1999,109:613-616.
  • 7[7]Naim R,Shen T,Riedel F,et al.Regulation of apoptosis in external auditory canal cholesteatoma by hepatocyte growth factor/scatter factor.ORL J Otorhinolaryngol Relat Spec,2005,67:45-50.
  • 8Syms MJ, Luxford WM. Management of cholesteatoma:status of the canal wall. Laryngoscope,2003,113:443-448.
  • 9Fageeh NA,Schloss MD,Elahi MM,et al.Surgical treatment of cholesteatoma in children.J Otolaryngol,1999,28:309-312.
  • 10Dodson EE, Hashisaki GT, Hobgood TC,et al.Intact canal wall mastoidectomy with tympanoplasty for cholesteatoma in children.Laryngoscope,1998,108:977-983.

共引文献17

同被引文献24

  • 1梁象逢,区永康,陈穗俊,郑亿庆,丁健慧,许耀东,杨芳,陈玲.儿童与成人慢性化脓性中耳炎听力学分析[J].听力学及言语疾病杂志,2004,12(5):313-314. 被引量:3
  • 2张全安,张青,郑国玺,樊孟耘.胆脂瘤型中耳炎形成的局部炎性浸润和刺激的病理机理研究[J].中华耳鼻咽喉头颈外科杂志,2005,40(1):6-9. 被引量:16
  • 3梁象逢,陈穗俊,区永康,郑亿庆,丁健慧,许耀东,杨芳,陈玲.儿童与成人慢性化脓性中耳炎的临床分析[J].临床耳鼻咽喉科杂志,2005,19(13):594-596. 被引量:23
  • 4惠莲,姜学钧,杨柠.小儿胆脂瘤型中耳炎的鼓室成形术[J].中华耳鼻咽喉头颈外科杂志,2005,40(9):653-656. 被引量:10
  • 5Jin-Hyeok J,Chul-Won P,Kyung T,et al.Expression of RANKL and OPG in middle ear cholesteatoma tissue[J].Laryngoscope,2006,116(7):1180-1184.
  • 6Soysa NS,Alles N,Takahashi M,et al.Defective nuclear factor-κB-inducing kinase in aly/aly mice prevents bone resorption induced by local injection of lipopolysaccharide[J].J Periodont Res,2011,46(2):280-284.
  • 7Castellano D,Sepulveda JM,García-Escobar I,et al.The role of RANK-ligand inhibition in cancer:The story of denosumab[J].Oncologist,2011,16(2):136-145.
  • 8Skotnicka B,Hassmann-Poznańska E.Clinical and pathological features of cholesteatoma in young children[J].Otolaryngol Pol,2010,64(6):375-381.
  • 9Jesús B,Anja H,Francisco AC,et al.Immunobiological peculiarities of cholesteatoma in children:Quantification of epithelial proliferation by MIB 1[J].Laryngoscope,1996,106(7):865-868.
  • 10Spilsbury K,Miller I,Semmens JB,et al.Factors associated with developing cholesteatoma:A study of 45,980 children with middle ear disease[J].Laryngoscope,2010,120(3):625-630.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部